OTCMKTS:QPWR QSAM Biosciences (QPWR) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About QSAM Biosciences Stock (OTCMKTS:QPWR) 30 days 90 days 365 days Advanced Chart Get QSAM Biosciences alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume437,200 shsAverage Volume68,770 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview QSAM Biosciences, Inc. (OTCMKTS:QPWR) is a clinical-stage biotechnology company focused on the development of adoptive T-cell immunotherapies for the treatment of solid tumors. The company’s core innovation is its proprietary QDive platform, a microengraving-based, high-throughput single-cell screening system designed to identify and enrich rare, high-avidity T-cell receptors (TCRs) capable of targeting tumor-associated antigens with precision. The QDive platform enables parallel functional assays on millions of individual T cells to rapidly select lead candidates based on cytokine secretion, cytotoxic potential and antigen specificity. QSAM applies this approach to a pipeline of preclinical programs addressing antigens such as PSMA, mesothelin and MAGE-A4 in malignancies including prostate, ovarian and pancreatic cancers, with the goal of advancing optimized TCR-T cell products toward clinical evaluation. Headquartered in Dallas, Texas, QSAM Biosciences collaborates with academic institutions and industry partners across North America and Europe to support its research and development efforts. The company’s leadership team brings together experts in immuno-oncology, cell therapy manufacturing and translational research, with a shared mission to translate innovative T-cell discovery technology into novel treatment options for patients with hard-to-treat solid tumors.AI Generated. May Contain Errors. Read More Receive QPWR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for QSAM Biosciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. QPWR Stock News HeadlinesQSAM Biosciences Inc QSAMFebruary 16, 2024 | morningstar.comMTelix to acquire QSAM Biosciences for $123.1mFebruary 8, 2024 | msn.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.September 13 at 2:00 AM | Brownstone Research (Ad)QSAM Biosciences signs term sheet to be acquired by Telix PharmaceuticalsNovember 14, 2023 | msn.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Inks Supply Agreement with Leading Nuclear Medicine Pharmacy NetworkMay 17, 2023 | marketwatch.com8-K: QSAM Biosciences, Inc.May 13, 2023 | marketwatch.comQSAM Biosciences Receives Second Key Patent in Europe for its Clinical Stage Radiopharmaceutical Drug Candidate, CycloSam(R)April 27, 2023 | marketwatch.comInvestorNewsBreaks - QSAM Biosciences Inc. (QSAM) Phase 1 CycloSam(R) Study Ready to Open Cohort 2 EnrollmentApril 5, 2023 | marketwatch.comSee More Headlines QPWR Stock Analysis - Frequently Asked Questions How do I buy shares of QSAM Biosciences? Shares of QPWR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of QSAM Biosciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that QSAM Biosciences investors own include Rocket Lab (RKLB), Atlas Lithium (ATLX), Archer Aviation (ACHR), Cyclone Power Technologies (CYPW), OriginOil (OCLN), BlackSky Technology (BKSY) and Baltic International USA (BISA). Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorIndustrials Industry Waste Management Sub-IndustryConsumer Goods Current SymbolOTCMKTS:QPWR CIK1310527 Webq2earth.com Phone(561) 693-1423FaxN/AEmployees4Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:QPWR) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much b...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding QSAM Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share QSAM Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.